A medical centre in Jupiter, Florida in the US has recently improved its patient and staff safety measures with the installation of two Tru-D SmartUVC disinfection robots.
After researching the market for UVC disinfection systems, Jupiter Medical Centre said it chose Tru-D for its 'intuitive technology, smart data tracking capability and proven efficiency in real-world settings'.
Tru-D SmartUVC delivers an automated, measured dose of UVC to consistently disinfect an entire room from a single position. The patented design ensures 99.99% pathogen reduction in direct and shadowed areas and eliminates human error as well as documents disinfection results for each cycle.
The Tru-D robots were purchased thanks to the generosity of the Jupiter Medical Centre's Auxiliary. The hospital volunteer group wanted to provide a gift that would have a direct impact on patient care and safety.
More on best practice in the areas of hand hygiene, compliance, monitoring, room sterilisation and water treatment at the 2016 Infection Prevention and Containment ConferenceFind out more
The Tru-D robots were great additions to our existing tools
'Our Auxiliary is dedicated to assisting us in providing excellent care and had a desire to purchase technology that could do so. Jupiter Medical Centre is known for providing world-class quality. We are consistently keeping a close eye on ways in which we can add to our infection prevention and quality outcome measures, and the Tru-D robots were great additions to our existing tools. We are grateful to our Auxiliary for sharing our commitment to quality, and providing us with this gift,' said Steve Seeley, Vice President, Chief Operating Officer and Chief Nursing Officer of Jupiter Medical Centre.
Chuck Dunn, President and CEO of Tru-D SmartUVC, added: 'The Tru-D robots not only allow Jupiter Medical Centre to adhere to its mission of providing world class healthcare, but also reinforce its standing as a leading healthcare organisation in its region.'
Tru-D has been validated by more than a dozen scientific third-party studies. Most recently, results of research funded by the Centers for Disease Control and Prevention in the US, Benefits of Enhanced Terminal Room Disinfection, found that enhanced terminal room disinfection strategies decreased the cumulative incidence of multidrug-resistant organisms by 10–30%, and the largest decreases were seen when Tru-D was added to the standard cleaning strategy.
